loading...

Anti-Clot Treatment Scale (ACTS)

Cano S; Lamping DL

Distributed by Mapi Research Trust

ProQolid

Distributed by Mapi Research Trust

Basic description

Developed in 2006

Authors

Cano S; Lamping DL

with a research grant provided by Bayer Pharma AG (Germany)
Copyright
ACTS © Bayer AG, 2006. All Rights Reserved.
Objective
To measure patient treatment satisfaction with anticoagulation treatment
Therapeutic area
  • Cardiovascular Diseases
  • Respiratory Tract Diseases
Therapeutic indication
  • Pulmonary Embolism
  • Venous Thrombosis
Patients receiving long-term anticoagulation irrespective of the underlying condition
Type of Clinical Outcome Assessment (COA)
  • pro PRO
Original language(s)
  • English for the UK
Bibliographic reference(s) of the original questionnaire

Cano SJ, Lamping DL, Bamber L, Smith S. The Anti-Clot Treatment Scale (ACTS) in clinical trials: cross-cultural validation in venous thromboembolism patients. Health Qual Life Outcomes. 2012 Sep 26;10:120 (Full Text article)

Access this questionnaire

Please proceed below

Login SIGN up free

Contact and conditions of use

Authors

Cano S; Lamping DL

Dr Stefan Cano
Scale Report Ltd
16 Salisbury Close
Stotfold
SG5 4FL
UK
E-Mail: stefanjcano@gmail.com

Stefan Cano Publications (Pubmed)

Contact information

Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66

Conditions of use

Non-Commercial Users

You may access available translations of the questionnaire directly (see tutorial). Should you not see the Download button, please contact us.

Commercial Users

All requests have to be submitted through our online request management:

  1. Log in or Register for free
  2. Submit your request (Tutorials are available on our FAQs)
  3. In order to accelerate the process, you may attach the User Agreement (even if not finalized) to your online request. 
  4. Our PROVIDE team will get back to you with the needed information in a timely manner

Review copy

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

Languages

Original language(s)

  • English for the UK

Translations

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.

ACTS

Dutch for Belgium (Flemish)
Dutch for the Netherlands
English for Canada
French for Belgium
French for Canada
French for France
German for Germany
Italian for Italy
Japanese for Japan*
Mandarin for China
Portuguese for Portugal*
Russian for Russia
Spanish for Colombia
Spanish for Mexico
Spanish for Spain
Swedish for Sweden
* Performed by Mapi

Conditions to translate

Academic Translation

If you wish to translate the questionnaire:

  1. Log in or Register for free
  2. Submit your request for translation online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will send you a translation agreement along with Linguistic Validation Guidelines.

Commercial Users

Please submit a request online to sign a translation agreement:

  1. Log in or Register for free
  2. Submit your request online (Tutorials are available on our FAQs)
  3. Our PROVIDE team will get back to you with the needed information in a timely manner

E-versions

Tablet

Implemented electronically by EXOM GROUP  

Member Access

Subscribe to PROQOLID to access to full information

Access to advanced descriptions of Clinical Outcome Assessments (COAs)

A question? Contact us